乳胶过敏市场（2026—2031）
乳胶过敏市场规模预计由2026年的20.9亿美元增至2031年的27.8亿美元，预测期复合年增长率为5.93%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
乳胶过敏市场规模预计由2026年的20.9亿美元增至2031年的27.8亿美元，预测期复合年增长率为5.93%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 5.93% | 机构预测 |
| 市场规模 | 2026 | USD 2.09 billion | 机构预测 |
| 市场规模 | 2031 | USD 2.78 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| allergen_type | natural rubber latex | 2025 | 73.880% |
| end_user | hospitals and clinics | 2025 | 41.650% |
| geography | North America | 2025 | 39.870% |
| offerings | the treatment | 2025 | 58.340% |
| reaction_type | allergic contact dermatitis | 2025 | 37.560% |
关键结论
- allergen_type 维度中，natural rubber latex 在 2025 年的公开份额为 73.88%。
- end_user 维度中，hospitals and clinics 在 2025 年的公开份额为 41.65%。
- geography 维度中，North America 在 2025 年的公开份额为 39.87%。
- offerings 维度中，the treatment 在 2025 年的公开份额为 58.34%。
- reaction_type 维度中，allergic contact dermatitis 在 2025 年的公开份额为 37.56%。
主要参与者
- Thermo Fisher Scientific
- Siemens Healthineers
- HYCOR Biomedical
- Stallergenes Greer
- Beckman Coulter
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Healthcare Worker Screening | +1.600% | Global, concentrated in North America, Europe, and Asia-Pacific healthcare hubs | Medium term (2-4 years) |
| Latex-Free Medical Product Adoption | +1.300% | Global, with early adoption in North America and Europe | Short term (≤ 2 years) |
| Surgical and Diagnostic Procedure Volumes | +1.100% | Global, with faster uptake in Asia-Pacific and South America | Short term (≤ 2 years) |
| Occupational Safety and Device Labeling | +0.600% | North America and Europe, with spillover to GCC and ASEAN | Medium term (2-4 years) |
| Latex-Fruit Syndrome Testing and Awareness | +0.400% | North America, Europe, Japan, and emerging Asia-Pacific and South America | Medium term (2-4 years) |
| Accelerator-Free Synthetic Glove Innovation | +0.300% | Global, with manufacturing activity in Malaysia, India, and China | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Latex-Free Alternative Procurement Costs | -0.800% | Global, most acute in South America, Middle East and Africa, and emerging Asia-Pacific economies | Short term (≤ 2 years) |
| Limited Latex Allergen Test Standardization | -0.500% | Global, especially markets with fragmented laboratory accreditation | Medium term (2-4 years) |
| Verification of Latex-Free Product Claims | -0.400% | Global, with significant relevance in Asia-Pacific and South America | Medium term (2-4 years) |
| Performance Trade-Offs in Selected Alternatives | -0.300% | Global, concentrated in high-acuity surgical settings | Long term (≥ 4 years) |
报告关注的关键问题
What is driving growth in the Latex Allergy Market?
The Latex Allergy Market is forecast to grow at a 5.93% CAGR from 2026 to 2031, supported by healthcare worker screening, latex-free procurement, and greater diagnostic use.
Which offering has the largest revenue position?
Treatment held 58.34% of revenue in 2025, while diagnosis is forecast to grow faster at an 8.72% CAGR through 2031.
Why are latex-free gloves important for healthcare providers?
They reduce exposure to natural rubber latex and may also address sensitization risks associated with selected rubber chemical accelerators.
Which region is growing fastest?
Asia-Pacific is forecast to expand at a 9.26% CAGR through 2031, supported by healthcare investment and exposure among natural rubber manufacturing workers.
What treatment approach is growing fastest?
Immunotherapy and desensitization are forecast to grow at an 11.24% CAGR through 2031, the fastest treatment subsegment rate.
Is the Latex Allergy Market concentrated?
The Latex Allergy Market concentration score is 5 of 10 because diagnostics, immunotherapy, and protective-product supply are led by different companies, with no top-player combined share disclosed that would indicate high concentration.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence